Merck KGaA says it has completed the acquisition of life science company Millipore (Billerica, MA) for a total purchase price including debt and cash of about €5.2 billion ($6.6 billion). Merck KGaA agreed to acquire Millipore in February for $107/share in cash. Merck KGaA will now begin the process of de-listing the shares of Millipore from the New York Stock Exchange and removing the shares from registration with the U.S. Securities and Exchange Commission. Merck Chemicals now comprises two new divisions - Merck Millipore and Performance Materials...